User profiles for C.D. Russell
 | Clark D. RussellClinical Lecturer in Infectious Diseases, University of Edinburgh Verified email at ed.ac.uk Cited by 13323 |
Comorbidities, multimorbidity and COVID-19
The influence of comorbidities on COVID-19 outcomes has been recognized since the earliest
days of the pandemic. But establishing causality and determining underlying mechanisms …
days of the pandemic. But establishing causality and determining underlying mechanisms …
[HTML][HTML] Regulation of leptin production in humans
SK Fried, MR Ricci, CD Russell, B Laferrère - The Journal of nutrition, 2000 - Elsevier
Serum levels of the adipocyte hormone leptin are increased in proportion to body fat stores
as a result of increased production in enlarged fat cells from obese subjects. In vitro studies …
as a result of increased production in enlarged fat cells from obese subjects. In vitro studies …
The human immune response to respiratory syncytial virus infection
CD Russell, SA Unger, M Walton… - Clinical microbiology …, 2017 - Am Soc Microbiol
Respiratory syncytial virus (RSV) is an important etiological agent of respiratory infections,
particularly in children. Much information regarding the immune response to RSV comes from …
particularly in children. Much information regarding the immune response to RSV comes from …
Genetic mechanisms of critical illness in COVID-19
…, S Walker, N Parkinson, MH Fourman, CD Russell… - Nature, 2021 - nature.com
Host-mediated lung inflammation is present 1 , and drives mortality 2 , in the critical illness
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Objective To characterise the clinical features of patients admitted to hospital with coronavirus
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
…, N Price, A Rambaut, DL Robertson, CD Russell… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians. The
clinical course of patients remains to be fully characterised, little data are available that …
clinical course of patients remains to be fully characterised, little data are available that …
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
Tissue-specific immunopathology in fatal COVID-19
Rationale: In life-threatening coronavirus disease (COVID-19), corticosteroids reduce mortality,
suggesting that immune responses have a causal role in death. Whether this deleterious …
suggesting that immune responses have a causal role in death. Whether this deleterious …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …